Clinical Trials Logo

Clinical Trial Summary

With this study the investigators want to test which is the best medical treatment for symptomatic adenomyosis affecting women undergoing IVF and with previous implantation failure, between Aromatase inhibitor plus GnRH analog versus GnRH alone, in term pregnancy rate and uterine volume reduction.


Clinical Trial Description

Recently it has been shown that adenomyosis negatively affects the pregnancy rate in IVF cycles. The investigators used in the past for the treatment of other benign gynecological diseases such as endometriosis and uterine myomas a combined therapy with Aromatase inhibitor plus GnRH analog. With this study the investigators want evaluate which is the best way to treat adenomyosis in order to obtain a higher pregnancy rate in women with symptomatic adenomyosis undergoing IVF who failed a previous IVF attempt. For these reasons the investigators set this controlled trial between GnRH analog plus Aromatase Inhibitor (3.75 mg monthly of Leuprolide plus 1.0mg day of Anastrazole for 3 months) versus an active comparator as GnRH analog alone (3.75 mg monthly of Leuprolide for 3 months) after the treatment patients will undergo embryo transfer of a cryopreserved blastocyst in a previous IVF cycle, and will be followed up for uterine dimension reduction and pain symptom reduction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03421639
Study type Interventional
Source Centre for Endocrinology and Reproductive Medicine, Italy
Contact
Status Active, not recruiting
Phase Phase 4
Start date December 1, 2017
Completion date September 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03660735 - The PIP Study - Pre- IVF Immune Profiling Study
Not yet recruiting NCT04528277 - Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis Phase 3
Recruiting NCT04998279 - Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women With History of RIF
Completed NCT03267797 - hCG-activated PBMC-therapy in RIF Patients N/A
Recruiting NCT04118959 - Role of Atosiban in Recurrent Implantation Failure
Recruiting NCT05343572 - Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium Early Phase 1
Not yet recruiting NCT02752568 - Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure N/A
Recruiting NCT04822207 - Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure N/A
Recruiting NCT03900780 - Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure N/A
Not yet recruiting NCT03549728 - Effect of Granulocyte Colony-stimulating Factor on Clinical Pregnancy Rate in Patients With Endometriosis Phase 2
Completed NCT03174964 - Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure Phase 2
Completed NCT03161340 - Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure Phase 2
Not yet recruiting NCT01278706 - Endometrial Biopsy Protocol for In Vitro Fertilization (IVF) N/A
Completed NCT00750451 - Low Molecular Weight Heparin in Recurrent Implantation Failure N/A
Not yet recruiting NCT03690830 - Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertilization N/A
Not yet recruiting NCT03355937 - Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure N/A
Recruiting NCT05169541 - Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Completed NCT04085783 - PRP in Recurrent Implantation Failure N/A
Not yet recruiting NCT03365466 - Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women N/A
Recruiting NCT04293068 - Effect of Reproductive Tract Microbiota on Pregnancy Outcome in IVF/ICSI